Remission or low disease activity as a target in systemic lupus erythematosus

Date
2019Author(s)
Ugarte-Gil, M.F.
Wojdyla, D.
Pons-Estel, G.J.
Pons-Estel, B.A.
Alarcón, G.S.
Metadata
Show full item recordAbstract
We read the report by Zen et al1 on the impact of lupus low disease activity state (LLDAS) on damage accrual with great interest and would like to congratulate the authors on their work. In this single-centre Caucasian cohort, followed for 7years, only 38 of their 293 patients (11.3%) failed to achieve LLDAS for at least 1year; moreover, of the 255 patients who achieved LLDAS for at least 1year, 246 (96.5%) also satisfied the definition of remission for the same length of time. And, in 214 (83.9%) patients, the duration of remission was the same as that of LLDAS. Being in LLDAS for at least 2years was associated with a reduced risk of damage; but, when remission was included in the multivariable model, remission for at least 2years was associated with a reduced risk of damage whereas LLDAS was not...
Collections
- Cartas al editor [122]
